Financials Athens Medical C.S.A.

Equities

IATR

GRS147233001

Healthcare Facilities & Services

Market Closed - Athens S.E. 10:11:38 2024-04-26 am EDT 5-day change 1st Jan Change
1.615 EUR 0.00% Intraday chart for Athens Medical C.S.A. -4.15% -12.47%

Valuation

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization 1 126.6 86.74 183 132.3 146.6 123.2
Enterprise Value (EV) 1 266.7 214.8 312.2 235.7 245.2 250.5
P/E ratio 48.2 x 8.06 x 24.1 x 31.6 x 9.74 x 18 x
Yield - - - - 4.14% 2.11%
Capitalization / Revenue 0.75 x 0.47 x 0.93 x 0.67 x 0.65 x 0.53 x
EV / Revenue 1.58 x 1.18 x 1.58 x 1.2 x 1.09 x 1.07 x
EV / EBITDA 11.5 x 9.07 x 12.7 x 12.8 x 7.79 x 9.07 x
EV / FCF -33.5 x 16.5 x 24.9 x 37.8 x 29.3 x -13.7 x
FCF Yield -2.98% 6.08% 4.01% 2.65% 3.41% -7.31%
Price to Book 2 x 1.21 x 2.31 x 1.59 x 1.44 x 1.19 x
Nbr of stocks (in thousands) 86,736 86,736 86,736 86,736 86,736 86,736
Reference price 2 1.460 1.000 2.110 1.525 1.690 1.420
Announcement Date 4/30/18 4/25/19 6/30/20 4/29/21 4/29/22 4/27/23
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales 1 169.3 182.7 197.3 196.9 226 233.4
EBITDA 1 23.23 23.69 24.67 18.39 31.48 27.64
EBIT 1 13.98 15.94 16.4 9.689 22.73 18.28
Operating Margin 8.26% 8.72% 8.31% 4.92% 10.06% 7.83%
Earnings before Tax (EBT) 1 5.798 9.409 10.77 5.504 15.34 10.71
Net income 1 2.627 10.76 7.589 4.185 15.05 6.846
Net margin 1.55% 5.89% 3.85% 2.13% 6.66% 2.93%
EPS 2 0.0303 0.1241 0.0875 0.0482 0.1735 0.0789
Free Cash Flow 1 -7.96 13.05 12.52 6.238 8.364 -18.32
FCF margin -4.7% 7.14% 6.35% 3.17% 3.7% -7.85%
FCF Conversion (EBITDA) - 55.1% 50.75% 33.91% 26.57% -
FCF Conversion (Net income) - 121.29% 164.98% 149.05% 55.57% -
Dividend per Share - - - - 0.0700 0.0300
Announcement Date 4/30/18 4/25/19 6/30/20 4/29/21 4/29/22 4/27/23
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt 1 140 128 129 103 98.7 127
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.031 x 5.406 x 5.237 x 5.622 x 3.134 x 4.609 x
Free Cash Flow 1 -7.96 13.1 12.5 6.24 8.36 -18.3
ROE (net income / shareholders' equity) 4.33% 16% 10.2% 5.21% 12.7% 6.74%
ROA (Net income/ Total Assets) 2.39% 2.76% 2.82% 1.54% 3.38% 2.74%
Assets 1 109.8 389.4 269.4 272.2 445.6 250.1
Book Value Per Share 2 0.7300 0.8300 0.9100 0.9600 1.180 1.190
Cash Flow per Share 2 0.0400 0.0500 0.0900 0.5700 0.6000 0.1900
Capex 1 5.83 7.96 16.3 7.08 11.3 15.9
Capex / Sales 3.45% 4.36% 8.25% 3.59% 4.99% 6.8%
Announcement Date 4/30/18 4/25/19 6/30/20 4/29/21 4/29/22 4/27/23
1EUR in Million2EUR
Estimates
  1. Stock Market
  2. Equities
  3. IATR Stock
  4. Financials Athens Medical C.S.A.